Top 10 Companies in India Hepatitis C Market | Insights & Key Players 2026

India Hepatitis C Market Overview

According to 6Wresearch, the India hepatitis C market is experiencing consistent growth due to rising awareness, increasing screening initiatives, and government-led elimination programs. This growth is largely driven by the availability of cost-effective generic direct-acting antivirals (DAAs), expansion of healthcare access, and strong domestic pharmaceutical manufacturing capabilities. The market is also witnessing increased demand for combination therapies that offer high cure rates with shorter treatment durations.

Competitive Landscape

The competitive landscape in India hepatitis C market is a mix of global pharmaceutical innovators and strong domestic generic drug manufacturers. These companies ensure affordability and accessibility by offering a wide range of antiviral therapies, from branded DAAs to low-cost generics for large patient populations.

Leading Players Operating in the India Hepatitis C Market:

1. Zydus Lifesciences Ltd.

A global pioneer in the hepatology segment, Zydus provides sophisticated SoviHep solutions that handle complex viral loads and large-scale public health procurement.

2. Natco Pharma Limited

A major force in the oncology and antiviral space, Natco focuses on the Hepcinat range, offering breakthrough affordability and high-cure-rate generics for domestic and export markets.

3. Cipla Limited

A historic innovator in respiratory and antiviral tech, Cipla is renowned for its Hepcvir brand and strategic partnerships to expand diagnostic access across small and medium health centers.

4. Hetero Healthcare Limited

A fast-growing leader in the antiviral segment that provides an end-to-end hepatology suite, integrating the Velasof brand with comprehensive patient support programs.

5. Mylan Pharmaceuticals

Caters to the modern clinical workforce with a platform that emphasizes transparency in global quality standards for its MyHep All pan-genotypic range.

6. Dr. Reddy’s Laboratories

Combines chemical excellence with software-backed supply chains, offering the Resof brand and ensuring consistent availability across the pan-India hospital network.

7. Abbott India Limited

A mobile-first diagnostic and nutrition platform that leverages high-precision screening tools to provide early detection and system processing for chronic liver care.

8. Lupin Limited

Part of the global generic ecosystem, this brand focuses on providing affordable, highly customizable treatment protocols integrated with broad digital health applications.

9. Sun Pharmaceutical Industries Ltd.

Leverages decades of global R&D experience to provide technology-enabled specialty medicines tailored for the Indian private corporate healthcare sector.

10. Emcure Pharmaceuticals

Provides high-volume manufacturing and workforce management solutions, supporting some of the largest government-tendered hepatitis eradication programs.